Japan Periodontal Disease Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Gingivitis, Chronic Periodontal Disease, Aggressive Periodontal Disease, Type 4, and Type 5), By Application (Non-Surgical and Surgical), and Japan Periodontal Disease Market Insights, Industry Trend, Forecasts to 2035

Industry: Healthcare

RELEASE DATE Jun 2025
REPORT ID SI11856
PAGES 185
REPORT FORMAT PathSoft

Japan Periodontal Disease Market Insights Forecasts to 2035

  • The Japan Periodontal Disease Market Size Was Estimated at USD 222.42 Million in 2024
  • The Market Size is Expected to Grow at a CAGR of around 6.49% from 2025 to 2035
  • The Japan Periodontal Disease Market Size is Expected to Reach USD 444.10 Million by 2035

Japan Periodontal Disease Market

Get more details on this report -

Request Free Sample PDF

According to a research report published by Spherical Insights & Consulting, the Japan Periodontal Disease Market Size is Anticipated to reach USD 444.10 Million by 2035, growing at a CAGR of 6.49% from 2025 to 2035. The rising elderly population in Japan and increased awareness about oral hygiene are driving demand for periodontal treatments. Additionally, government-supported dental check-up programs and innovations in minimally invasive dental procedures are supporting market growth.

 

Market Overview

The Japan periodontal disease market refers to the healthcare segment focused on the diagnosis, prevention, and treatment of periodontal (gum) diseases, including gingivitis and periodontitis. In Japan, periodontal care is changing as a result of dental technological advancements. Treatment is now more widely available, more efficient, and less painful for patients because to the development of minimally invasive methods like laser treatments and regenerative therapies. Professional periodontal treatment is increasingly preferred over conventional approaches due to the faster recovery times and more accurate interventions made possible by these technologies. As these developments progress, it is anticipated that the market will continue to expand as more patients and dental professionals adopt state-of-the-art procedures.

 

Report Coverage

This research report categorizes the market for the Japan periodontal disease market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan periodontal disease market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan periodontal disease market.

 

Japan Periodontal Disease Market Report Coverage

Report CoverageDetails
Base Year:2024
Market Size in 2024:USD 222.42 Million
Forecast Period:2025-2035
Forecast Period CAGR 2025-2035 :6.49%
2035 Value Projection:USD 444.10 Million
Historical Data for:2020-2023
No. of Pages:185
Tables, Charts & Figures:115
Segments covered:By Product Type, By Application and COVID-19 Impact Analysis
Companies covered::Medtronic Japan Co., Ltd., DENTSPLY Sirona K.K., 3M Japan Limited, Pfizer Japan Inc., Novartis Pharma K.K and others key players.
Pitfalls & Challenges:COVID-19 Empact, Challenges, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

The aging population, growing awareness of oral health, and the increasing frequency of periodontal diseases are the main factors driving the periodontal disease market in Japan. The demand for diagnostic and therapeutic treatments is driven by the increased incidence of periodontal diseases in the aging population. The industry is also expanding as a result of the use of cutting-edge dental technologies including regenerative therapies and laser treatments. More people are seeking treatment as a result of growing awareness efforts about the significance of oral hygiene and its connections to general health. Further supporting market expansion are the growing number of specialized dentistry clinics and the integration of periodontal disease management into standard medical services.

 

Restraining Factors

The market for periodontal disease in Japan is beset by issues like high treatment prices and inadequate reimbursement coverage for sophisticated procedures, which restrict access for middle- and low-income groups despite improvements in dental care. Additionally, early identification and treatment are hindered by a lack of periodontists in rural areas and a cultural propensity to put off dental visits until symptoms develop.

 

Market Segmentation

The Japan periodontal disease market share is classified into product type and application.

 

  • The chronic periodontal disease segment accounted for the largest revenue in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan periodontal disease market is segmented by product type into gingivitis, chronic periodontal disease, aggressive periodontal disease, type 4, and type 5. Among these, the chronic periodontal disease segment accounted for the largest revenue in 2024 and is expected to grow at a significant CAGR during the forecast period. This is primarily due to its high prevalence among the aging population, which is a significant demographic factor in Japan. As individuals grow older, they become more susceptible to periodontal conditions, leading to increased demand for diagnostic and therapeutic treatments.

 

  • The non-surgical segment accounted for the largest revenue in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan periodontal disease market is segmented by application into non-surgical and surgical. Among these, the non-surgical segment accounted for the largest revenue in 2024 and is expected to grow at a significant CAGR during the forecast period. Particularly for less severe forms of periodontal disease like gingivitis, non-surgical therapies like scaling, root planing, and the use of antimicrobial agents are frequently employed.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan periodontal disease market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • Medtronic Japan Co., Ltd.
  • DENTSPLY Sirona K.K.
  • 3M Japan Limited
  • Pfizer Japan Inc.
  • Novartis Pharma K.K
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Japan Periodontal Disease Market based on the below-mentioned segments:

 

Japan Periodontal Disease Market, By Product Type

  • Gingivitis
  • Chronic Periodontal Disease
  • Aggressive Periodontal Disease
  • Type 4
  • Type 5

 

Japan Periodontal Disease Market, By Application

  • Non-Surgical
  • Surgical

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies